Recombinant human albumin supports single cell cloning of CHO cells in chemically defined media

Biotechnology Progress

Volumn 28, Issue 3, 2012, Pages 887-891

  Zhu, Jiang ^a   Wooh, Jong Wei ^a   Hou, Jeff Jia Cheng ^a   Hughes, Benjamin S ^a   Gray, Peter P ^a   Munro, Trent P ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

CHO cells; Recombinant albumin; Single cell cloning

Indexed keywords

BIOLOGIC DRUGS; CELL DENSITY CULTURE; CELL LINES; CHINESE HAMSTER OVARY CELLS; CHO CELL; FETAL BOVINE SERUM; GROWTH MEDIA; MAMMALIAN CELLS; PROCESS CONSISTENCY; PROTEIN-FREE; RECOMBINANT ALBUMIN; RISK OF CONTAMINATION; SINGLE CELLS;

ANIMAL CELL CULTURE; BODY FLUIDS; CLONING; CYTOLOGY; MOLECULAR BIOLOGY; MONOCLONAL ANTIBODIES;

CLONE CELLS;

ALBUMINOID; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; CHO CELL; CLONING; CRICETULUS; HAMSTER; HUMAN; METABOLISM;

ALBUMINS; ANIMALS; CHO CELLS; CLONING, ORGANISM; CRICETINAE; CRICETULUS; HUMANS; RECOMBINANT PROTEINS;

ANIMALIA; BOVINAE; CRICETULUS GRISEUS; MAMMALIA;

EID: 84862214655     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.1549     Document Type: Article

References (28)

1. La Merie Business Intelligence. Top 30 Biologics 2010; March 3, 2011.
2. Wurm FM, Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol. 2004; 22: 1393-1398.
3. Butler M, Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals. Appl Microbiol Biotechnol. 2005; 68: 283-291.
4. Jayapal KR, Wlaschin KF, Hu WS, Yap MGS, Recombinant protein therapeutics from CHO cells-20 years and counting. Chem Eng Prog. 2007; 103: 40-47.
5. Jayme DW, Smith SR, Media formulation options and manufacturing process controls to safeguard against introduction of animal origin contaminants in animal cell culture. Cytotechnology. 2000; 33: 27-36.
6. Castle P, Robertson JS, Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals. 5-6 May 1998, Strasbourg, France. Biologicals. 1998; 26: 365-368.
7. van der Valk J, Brunner D, De Smet K, Fex Svenningsen A, Honegger P, Knudsen LE, Lindl T, Noraberg J, Price A, Scarino ML, Gstraunthaler G, Optimization of chemically defined cell culture media-replacing fetal bovine serum in mammalian in vitro methods. Toxicol In Vitro. 2010; 24: 1053-1063.
8. Hamilton WG, Ham RG, Clonal growth of chinese hamster cell lines in protein-free media. In Vitro. 1977; 13: 537-547.
9. Munro TP, Pilbrough W, Hughes BS, Gray PP, The biological basis. In: Moo-Young, M, editor. Comprehensive Biotechnology, 2nd ed. Elsevier; 2011: 169-178; Vol. 1.
10. Browne SM, Al-Rubeai M, Selection methods for high-producing mammalian cell lines. Trends Biotechnol. 2007; 25: 425-432.
11. Mattanovich D, Borth N, Applications of cell sorting in biotechnology. Microb Cell Fact. 2006; 5: 12.
12. McKeehan WL, Barnes D, Reid L, Stanbridge E, Murakami H, Sato GH, Frontiers in mammalian cell culture. In Vitro Cell Dev Biol. 1990; 26: 9-23.
13. Carter DC, Ho JX, Structure of serum albumin. Adv Protein Chem. 1994; 45: 153-203.
14. Francis GL, Albumin and mammalian cell culture: implications for biotechnology applications. Cytotechnology. 2010; 62: 1-16.
15. Quinlan GJ, Martin GS, Evans TW, Albumin: biochemical properties and therapeutic potential. Hepatology. 2005; 41: 1211-1219.
16. Ham RG, Albumin replacement by fatty acids in clonal growth of mammalian cells. Science. 1963; 140: 802-803.
17. Ham RG, An improved nutrient solution for diploid Chinese hamster and human cell lines. Exp Cell Res. 1963; 29: 515-526.
18. Moskowitz M, Schenck DM, Growth promoting activity for mammalian cells in fractions of tissue extracts. Exp Cell Res. 1965; 38: 523-535.
19. Nilausen K, Role of fatty acids in growth-promoting effect of serum albumin on hamster cells in vitro. J Cell Physiol. 1978; 96: 1-14.
20. Kunas KT, Papoutsakis ET, Damage mechanisms of suspended animal cells in agitated bioreactors with and without bubble entrainment. Biotechnol Bioeng. 1990; 36: 476-483.
21. Smith CG, Greenfield PF, Mechanical agitation of hybridoma suspension cultures: Metabolic effects of serum, pluronic F68, and albumin supplements. Biotech Bioeng. 1992; 40: 1045-1055.
22. Hulscher M, Pauli J, Onken U, Influence of protein-concentration on mechanical cell-damage and fluid-dynamics in airlift reactors for mammalian-cell culture. Food Biotechnol. 1990; 4: 157-166.
23. Hesse F, Ebel M, Konisch N, Sterlinski R, Kessler W, Wagner R, Comparison of a production process in a membrane-aerated stirred tank and up to 1000-L airlift bioreactors using BHK-21 cells and chemically defined protein-free medium. Biotechnol Prog. 2003; 19: 833-843.
24. Menezo Y, Testart J, Perrone D, Serum is not necessary in human in vitro fertilization, early embryo culture, and transfer. Fertil Steril. 1984; 42: 750-755.
25. Quinn P, Carter DC, Ye P, Behr B, The use of recombinant human serum albumin (rHSA) for mouse IVF and embryo culture: Effect of diluent and protein stabilizers. Fertil Steril. 2005; 83: S24-S24.
26. Bungum M, Humaidan P, Bungum L, Recombinant human albumin as protein source in culture media used for in vitro fertilization, a prospective randomized study. Fertil Steril. 2002; 78: S56-S57.
27. Blake D, Svalander P, Jin M, Silversand C, Hamberger L, Protein supplementation of human IVF culture media. J Assist Reprod Genet. 2002; 19: 137-143.
28. Kobayashi K, Summary of recombinant human serum albumin development. Biologicals. 2006; 34: 55-59.